Baltimore accuses drug makers of delaying generic Seroquel XR
MLex Summary: The City of Baltimore filed a proposed class action against AstraZeneca Pharmaceuticals, Handa Pharmaceuticals and Par Pharmaceutical, accusing them of engaging in an unlawful agreement to delay generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article